Cacti Asset Management LLC Sells 7,067 Shares of CVS Health Corporation $CVS

Cacti Asset Management LLC lessened its stake in shares of CVS Health Corporation (NYSE:CVS) by 1.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 398,293 shares of the pharmacy operator’s stock after selling 7,067 shares during the period. CVS Health accounts for 2.0% of Cacti Asset Management LLC’s portfolio, making the stock its 17th largest holding. Cacti Asset Management LLC’s holdings in CVS Health were worth $30,179,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Avion Wealth lifted its position in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the period. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health during the second quarter worth about $30,000. Bell Investment Advisors Inc raised its position in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the last quarter. Front Row Advisors LLC boosted its position in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares during the last quarter. Finally, Roxbury Financial LLC lifted its stake in CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS opened at $79.45 on Monday. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. The firm’s fifty day simple moving average is $78.97 and its two-hundred day simple moving average is $71.98. The stock has a market capitalization of $100.85 billion, a P/E ratio of 209.08, a price-to-earnings-growth ratio of 0.78 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the firm posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is currently 700.00%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on CVS shares. Mizuho increased their target price on CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Evercore ISI increased their price target on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. TD Cowen boosted their price objective on CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Sanford C. Bernstein lifted their price target on CVS Health from $86.00 to $87.00 and gave the company a “market perform” rating in a research note on Friday. Finally, Wolfe Research upped their price objective on CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, December 8th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $93.71.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.